Sun Pharmaceutical Recalls Vecuronium Bromide Injection Due to Glass Particles
Sun Pharmaceutical Industries is recalling Vecuronium Bromide for Injection because glass particles were detected in the product.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The agency classification is FDA Class I, which mandates a severity score of at least 4 per the rubric.
Plain-English summary
Sun Pharmaceutical Industries, Inc. is recalling Vecuronium Bromide for Injection 20 mg, a prescription medication used for intravenous administration. The recall was initiated because foreign matter identified as glass was detected in the product.
The affected product consists of 1,384 cartons containing 13,840 vials. The specific lot number is JKS0400A, with an expiration date of 03/2019. The product was distributed nationwide in the USA.
Healthcare providers and patients should discontinue use of the affected lot and contact their supplier or Sun Pharmaceutical Industries for further instructions.
The recalled product
- Product
- VECURONIUM BROMIDE (VECURONIUM BROMIDE)
- Brand
- VECURONIUM BROMIDE
- Manufacturer
- Sun Pharmaceutical Industries, Inc.
- Category
- Drug — Prescription Injection
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: JKS0400A
- EXP 03/2019
UPCs (1)
- 0347335932447
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 2 recalled by Sun Pharmaceutical Industries, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same brand · VECURONIUM BROMIDE
- CriticalSun Pharmaceutical Recalls Vecuronium Bromide Due to Glass Particulates
FDA (Drugs) · 2019-01-16
Same manufacturer · Sun Pharmaceutical Industries, Inc.
See all →- HighSun Pharmaceutical Recalls Carbamazepine Tablets Due to Manufacturing Deviations
FDA (Drugs) · 2026-08-26
- LowFexofenadine Hydrochloride Tablets 180 mg Recalled for Impurities
FDA (Drugs) · 2026-07-08
- HighPerampanel Prescription Tablets Recalled for Labeling Mix-up
FDA (Drugs) · 2026-07-01
- HighBudesonide inhalation ampules contain black and brown specks and particles
FDA (Drugs) · 2026-06-17
- SevereDoxorubicin liposome injection vials contain glass particulate matter
FDA (Drugs) · 2026-06-17
Same hazard · foreign matter
See all →- SevereSpectra Medical Devices Recalls Sodium Chloride Injection Ampules Due to Sterility Concerns
FDA (Devices) · 2026-08-19
- HighLidocaine Injection Recall Due to Hair Contamination
FDA (Drugs) · 2026-07-29
- ModerateDivalproex Sodium Delayed-Release Tablets Recalled Due to Presence of Foreign Tablets
FDA (Drugs) · 2026-07-29
- ModeratePasteurized donor human milk bottles show dark spot contamination
FDA (Food) · 2026-06-17
- ModerateVitamin B-Complex and Vitamin C Dietary Supplement Recalled for Foreign Matter
FDA (Food) · 2026-05-27